AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 2 filers reported holding AXSOME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,323,297 | +390.0% | 18,934 | +403.8% | 0.00% | – |
| Q2 2023 | $270,050 | +13.9% | 3,758 | -2.2% | 0.00% | – |
| Q1 2023 | $237,098 | -16.0% | 3,844 | +5.1% | 0.00% | – |
| Q4 2022 | $282,219 | -5.9% | 3,659 | -17.6% | 0.00% | – |
| Q2 2021 | $300,000 | +16.3% | 4,441 | -2.6% | 0.00% | – |
| Q1 2021 | $258,000 | -55.4% | 4,558 | -35.8% | 0.00% | -100.0% |
| Q4 2020 | $578,000 | -6.8% | 7,099 | -18.4% | 0.00% | 0.0% |
| Q3 2020 | $620,000 | -3.0% | 8,697 | +11.9% | 0.00% | 0.0% |
| Q2 2020 | $639,000 | -51.5% | 7,769 | -65.3% | 0.00% | 0.0% |
| Q1 2020 | $1,318,000 | -6.9% | 22,420 | +63.8% | 0.00% | -50.0% |
| Q4 2019 | $1,415,000 | +673.2% | 13,687 | +51.7% | 0.00% | – |
| Q3 2019 | $183,000 | – | 9,022 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 785,683 | $60,599,730 | 58.10% |
| Fairmount Funds Management LLC | 2,011,647 | $155,158,333 | 24.61% |
| VR Adviser, LLC | 670,718 | $51,732,479 | 8.72% |
| Ghost Tree Capital, LLC | 235,000 | $18,126,000 | 7.74% |
| SVB FINANCIAL GROUP | 33,849 | $2,610,773 | 7.14% |
| Tri Locum Partners LP | 200,054 | $15,430,000 | 6.24% |
| BVF INC/IL | 1,755,000 | $135,363,150 | 5.71% |
| RTW INVESTMENTS, LP | 2,980,482 | $229,884,577 | 4.69% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $24,681,600 | 3.59% |
| PFM Health Sciences, LP | 1,092,831 | $84,290,055 | 3.02% |